Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group (original) (raw)
Khardori N, Bodey, GP . Infections in hematologic malignancies Hematology 1991 14: 363–424 Google Scholar
Verfaillie C, Weisdorf D, Haake R et al. Candida infections in bone marrow transplant recipients Bone Marrow Transplant 1991 8: 177–184 CASPubMed Google Scholar
Koll BS, Brown AE . Changing patterns of infections in the immunocompromised patient with cancer Hematol/Oncol Clin North Am 1993 7: 753–769 ArticleCAS Google Scholar
Heurlin N, Bergstrom SE, Winiarski J et al. Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantation Acta Paediatr 1996 85: 168–172 ArticleCAS Google Scholar
Gamis AS, Gudnason T, Giebink GS, Ramsay NKC . Disseminated infection with fusarium in recipients of bone marrow transplants Rev Infect Dis 1991 13: 1077–1088 ArticleCAS Google Scholar
Uderzo C, Angelo PD, Rizzari C et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies Bone Marrow Transplant 1991 9: 113–117 Google Scholar
Guiot HF, Fibbe WE, van't Wout JW . Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis Clin Infect Dis 1994 18: 525–532 ArticleCAS Google Scholar
Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation New Engl J Med 1992 326: 845–851 ArticleCAS Google Scholar
Winston DJ, Chandrasekar PH, Lazarus HM et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial Ann Intern Med 1993 118: 495–503 ArticleCAS Google Scholar
Slavin MA, Osborne B, Adams R et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation – a prospective, randomized, double-blind study J Infect Dis 1995 171: 1545–1552 ArticleCAS Google Scholar
Kruger W, Sobottka I, Stockschlader M et al. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values Scand J Infect Dis 1996 28: 313–316 ArticleCAS Google Scholar
Jehu V . Managing fungal and viral infections in the immunocompromised host Rec Res Cancer Res 1988 108: 61–70 Article Google Scholar
Winston DJ . Prophylaxis and treatment of infection in the bone marrow transplant recipient Curr Clin Topics Infect Dis 1993 13: 293–321 CAS Google Scholar
Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group New Engl J Med 1999 340: 764–771 ArticleCAS Google Scholar
Pasic S, Flannagan L, Cant AJ . Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency Bone Marrow Transplant 1997 19: 1229–1232 ArticleCAS Google Scholar
Chopra R, Fielding A, Goldstone AH . Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome) – a report on 40 cases from a single centre Leuk Lymphoma 1992 7: (Suppl1) 73–77 Article Google Scholar
Kruger W, Stockschlader M, Russmann B et al. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation Br J Haematol 1995 91: 684–690 ArticleCAS Google Scholar
Kruger W, Stockschlader M, Sobottka I et al. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation Leuk Lymphoma 1997 24: 491–499 ArticleCAS Google Scholar
Fluconazole Med Lett 1990 32: 50–52
Gotzsche PC, Johansen HK . Meta-analysis of prophylactic or empirical antifungal treatment vs placebo or no treatment in patients with cancer complicated by neutropenia Br Med J 1997 314: 1238–1244 ArticleCAS Google Scholar
Ehninger G, Schuler HK, Sarnow E . Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation Mycoses 1996 39: 259–263 Article Google Scholar
O'Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients J Clin Oncol 1994 12: 827–834 ArticleCAS Google Scholar
Powles RL, Milliken S . The prophylaxis of fungal infections J Antimicrob Chemother 1991 28: (Suppl. A) 97–103 Article Google Scholar
Quabeck K, Muller KD, Beelen DW et al. Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patients Mycoses 1992 35: 221–224 ArticleCAS Google Scholar
Tollemar J, Ringden O, Andersson S et al. Randomized double-blind study of liposomal amphotericin B (AmBisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients Bone Marrow Transplant 1993 12: 577–582 CASPubMed Google Scholar
Ringden O, Andstrom EE, Remberger M et al. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation Pediatr Transplant 1997 1: 124–129 CASPubMed Google Scholar
Perfect JR, Klotman ME, Gilbert CC et al. Prophylactic intravenous Amphotericin B in neutropenic autologous bone marrow transplant recipients J Infect Dis 1992 165: 891–897 ArticleCAS Google Scholar
Schwartz S, Behre G, Heinemann V et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial Blood 1999 93: 3654–3661 CASPubMed Google Scholar
Hertenstein B, Kern WV, Schmeiser T et al. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Ann Hematol 1994 68: 21–26 ArticleCAS Google Scholar
Kelsey SM, Goldman JM, McCann S et al. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study Bone Marrow Transplant 1999 23: 163–168 ArticleCAS Google Scholar
Wingard JR, Merz WG, Rinaldi MG et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole New Engl J Med 1991 325: 1274–1277 ArticleCAS Google Scholar
Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562–1568 ArticleCAS Google Scholar
De Laurenzi A, Matteocci A, Lanti A et al. Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995 Infection 1996 24: 361–366 ArticleCAS Google Scholar
Chandrasekar PH, Gatny CM . The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team J Antimicrob Chemother 1994 33: 309–318 ArticleCAS Google Scholar
Rousey SR, Russler S, Gottlieb M, Ash RC . Low-dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation Am J Med 1991 91: 484–492 ArticleCAS Google Scholar
Chandrasekar PH, Gatny CM . Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team Chemotherapy 1994 40: 136–143 ArticleCAS Google Scholar